论文部分内容阅读
目的观察米非司酮和米索前列醇配伍利凡诺对中期妊娠引产的疗效。方法将120例中期妊娠要求引产的的妇女,在引产前一天口服米非司酮75mg,利凡诺羊膜腔内注射引产的同时再次口服米非司酮75mg(观察组),并与同期120例单纯用利凡诺引产的中期妊娠妇女(对照组)进行比较。结果观察组120例宫颈Bishop评分均有升高,显效率为86.25%;流产时间缩短;与对照组比较差异有显著性。结论米非司酮和米索前列醇配伍利凡诺用于中期妊娠引产,宫颈成熟效果好,副反应轻微,完全流产率高,减少了清宫率,减少感染机会,同时引产时间显著缩短。
Objective To observe the curative effect of mifepristone and misoprostol compatibility rivanol on induction of labor during second trimester pregnancy. Methods A total of 120 women who required induction of labor during the second trimester of pregnancy were given mifepristone 75 mg on the day before induced labor and 75 mg of mifepristone (ovulation induction) A simple comparison of mid-term pregnant women induced with Rivanol (control group) was compared. Results 120 cases of Bishop cervical score increased in the observation group, markedly effective rate was 86.25%; abortion time was shortened; compared with the control group, the difference was significant. Conclusions Mifepristone and misoprostol are compatible with rivanol for inducing labor in the second trimester of pregnancy. Cervical maturation is effective with minor side effects and high complete abortion rate, which reduces the rate of curettage and reduces the chances of infection. Meanwhile, the induction time is significantly shortened.